Higher levels of soluble urokinase plasminogen activator receptor linked to incident venous thromboembolism independently of D-dimer
Cases of Kawasaki Disease in the U.S. Dropped During Pandemic
Kawasaki disease cases fell by 28 percent and remained low during periods of pandemic-related masking and school closures
Inflammation During COVID-19 Hospitalization Linked to Mortality
Elevated C-reactive protein during hospitalization associated with increased mortality risk after recovery from COVID-19
Age, Higher Ferritin Levels Linked to More Severe MIS-C
Children aged 13 to 17 years, 6 to 12 years, with initial ferritin levels >500 µg/L had increased risk for ICU admission
SARS-CoV-2 Vaccination Seems Safe After MIS-C
No major adverse events seen among 15 children with MIS-C who were subsequently vaccinated against SARS-CoV-2
MIS-C Rare in 12- to 20-Year-Olds After COVID-19 Vaccination
Reporting rate was 1.0 case per million vaccinated individuals and 0.3 cases among those without evidence of SARS-CoV-2 infection
Cardiac Outcomes Good for Children With COVID-19-Related MIS-C
All deformation parameters on echocardiogram recovered within first week, including LV global longitudinal strain, peak left atrial strain
Two Doses of BNT162b2 Vaccine Protect Against MIS-C
Two doses of Pfizer-BioNTech vaccine have estimated effectiveness of 91 percent against MIS-C in children aged 12 to 18 years
COVID-19 Vaccines Significantly Cut MIS-C Risk in Teens
Of 107 children hospitalized with multisystem inflammatory syndrome in children, none were fully vaccinated